The emergence of tau as a contributor to LRRK2 and VPS35 linked PD, the emerging aetiological overlap with the tauopathies and the existence of ready to use tauopathy models in C. elegans, provides further opportunities for functional studies and modifier screens of tau pathology, with impacts on multiple neurodegenerative conditions. This evidence concerns the gene LRRK2 and tauopathy.